Cas:87179-33-7 1-(3-Methoxy-4-methylphenyl)-2-propanamine manufacturer & supplier

Chemical Name:1-(3-Methoxy-4-methylphenyl)-2-propanamine

CAS.NO:87179-33-7

Synonyms:1-(3-Methoxy-4-methylphenyl)-2-propanamine

Molecular Formula:C₁₁H₁₇NO

Molecular Weight:179.25900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:271.8ºC at 760mmHg

Density:0.979g/cm3

Index of Refraction:

PSA:35.25000

Exact Mass:179.13100

LogP:2.59360

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(3-Methoxy-4-methylphenyl)-2-propanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3-Methoxy-4-methylphenyl)-2-propanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-Methoxy-4-methylphenyl)-2-propanamine Use and application,1-(3-Methoxy-4-methylphenyl)-2-propanamine technical grade,usp/ep/jp grade.

Related News: The group, after examining Soliris’ late-stage trial data, determined they’re highly certain it produces a small benefit to patients who are positive for anti-AChR antibodies, while there’s a “moderate certainty of a small or substantial net health benefit.” Vinylionol manufacturers This project is supported by the Irish Government through IDA Ireland. 6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxylic acid suppliers Johnson & Johnson’s COVID-19 vaccine presents greater benefits than it does safety risks, especially amid the quickly spreading Delta variant, a key CDC expert panel decided. However, the panel said that a ruling over the need for a booster added to all COVID shots will have to start with the FDA. 3-ethyl-2,3-dimethylpentane vendor & factory This project is supported by the Irish Government through IDA Ireland.,Johnson & Johnson’s COVID-19 vaccine presents greater benefits than it does safety risks, especially amid the quickly spreading Delta variant, a key CDC expert panel decided. However, the panel said that a ruling over the need for a booster added to all COVID shots will have to start with the FDA.